I joined the Lifespan Cancer Institue over 6 years ago as an academic breast and gynecologic medical oncologist. I also have a special interest in the treatment of young women with female cancers. I graduated from the University of New England School of Osteopathic Medicine in 2008. I attended University of Massachusetts for both Internal Medicine residency and Hematology Oncology fellowship. I am double boarded in Hematology and Oncology. I have a devotion to fellow specialty-trained education. I follow my pursuit of research in women's oncology and am passionate about providing stream-lined care and support to young females with cancer.
|Yankulina O, Zullo AR, Cabral SE, Huynh JP, Hutchinson JA, Lopresti ML, Fenton MA, Berard-Collins CM. "Pertuzumab-associated diarrhea in HER2/neu-positive breast cancer patients: A comparison of trials to actual practice." Journal of Oncology Pharmacy Practice, vol. 26, no. 4, 2020, pp. 1078155219879211.|
|Olszewski AJ, Chorzalska AD, Kim AS, Quesenberry PJ, Lopresti ML, Fenton MA, Reagan JL, Butera JN, Sahin I, Hamel C, Robison J, Petersen M, Dubielecka PM. "Clonal haematopoiesis of indeterminate potential among cancer survivors exposed to myelotoxic chemotherapy." British Journal of Haematology, vol. 186, no. 3, 2019, pp. e31-e35.|
|Ciambella CC, Taneja C, Dizon DS, Wiggins DL, Emmick CM, Leonard KL, Lopresti ML, Witherby S, Cabral D, Snow S, Graves TA. "Distress: Characterizing What Causes the Thermometer to Shift in Patients with Newly Diagnosed Breast Cancer Attending a Multidisciplinary Clinic." Annals of Surgical Oncology, vol. 26, no. 10, 2019, pp. 3204-3209.|
|Lopresti ML, Bandera CA, Miner TJ. "New Approaches to Improving Survival After Neoadjuvant Chemotherapy: The Role of Intraperitoneal Therapy and Heated Intraperitoneal Chemotherapy in Ovarian Cancer." American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Meeting, vol. 39, 2019, pp. 19-23.|
|Lopresti, Mary, Rizack, Tina, Dizon, Don S. "Sexuality, fertility and pregnancy following breast cancer treatment." Gland Surgery, vol. 7, no. 4, 2018, pp. 404-410.|
|Wang Y, Brodsky AS, Xiong J, Lopresti ML, Yang D, Resnick MB. "Stromal Clusterin Expression Predicts Therapeutic Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer." Clinical Breast Cancer, vol. 18, no. 3, 2018, pp. e373-e379.|
|ONOYAMA, SAGANO, QIU, LI, LOW, HOI PANG, CHANG, CHIEN-I, STROHSNITTER, WILLIAM C., NORWITZ, ERROL R., LOPRESTI, MARY, EDMISTON, KATHRYN, LEE, I-MIN, TRICHOPOULOS, DIMITRIOS, LAGIOU, PAGONA, HSIEH, CHUNG-CHENG. "Prenatal Maternal Physical Activity and Stem Cells in Umbilical Cord Blood." Medicine & Science in Sports & Exercise, vol. 48, no. 1, 2016, pp. 82-89.|
|Qiu, L., Onoyama, S., Low, H. P., Chang, C.-I., Strohsnitter, W. C., Norwitz, E. R., Lopresti, M., Edmiston, K., Lambe, M., Trichopoulos, D., Lagiou, P., Hsieh, C.-C. "Effect of preeclampsia on umbilical cord blood stem cells in relation to breast cancer susceptibility in the offspring." Carcinogenesis, vol. 36, no. 1, 2014, pp. 94-98.|
-PI, Co-PI in multiple BrUOG trials in Breast & Gynecological Malignancies
-Lifespan PI of National Cooperative Breast Protocol, Pallas Study
-Lifespan PI of Pharma-sponsored Triple Negative Breast Cancer Immunotherapy Trial
-PI, Investigator-initiated Feasibility of Childcare trial in women with breast or gynecological malignancies
-Translational collaboration with Michelle Dawson, PhD looking at tumor samples in young women diagnosed with breast cancer after pregnancy
-Translational collaboration with Dr. Wafik El-Deiry phI/II trial in metastatic BCA patients
-Retrospective quality assessment of Fertility referrals at Lifespan Cancer Institute
Laura Hull Trust Foundation Grant 2017 to support BrUOG 308: $28,250
Crowd Source Funding through Consano.org
Private Lifespan Donor Funding
I have presented work at San Antonio Breast Cancer Symposium in abstract form on mammary stem cells, breast cancer risk reduction and screening, and neoadjuvant chemotherapy.
I have given regional presentations on breast cancer at UMASS Cancer Center and at the University of New England College of Osteopathic Medicine.
I presented locally to my colleagues at Brown Grand Round Presentation on different topics in breast cancer, such as precision medicine and research advances.
|2008||DO||University of New England College of Osteopathic Medicine|
|2002||BS||University of Connecticut|
|Dawson, Michelle||Assistant Professor of Molecular Pharmacology, Physiology and Biotechnology|
Warren Alpert Medical School of Brown University, Academic Appointment
University of New England College of Osteopathic Medicine, Academic Appointment
Member of the Young Survivor's Coalition
|Hematology||American Board of Hematology, Hematology||2016-|
|Oncology||American Board of Oncology, Oncology||2014-|
|Internal Medicine||American Board of Internal Medicine, Internal medicine||2011-|
|Physician||State of Massachusetts||-|
|Physician||State of Rhode Island||-|
|Director of Young Women's Cancers. Lifespan Cancer Institute, 2018-|
|Director of the Young Fight Strong Program. Lifespan Cancer Institute, 2017-|
|Director of the Longitudinal Fellows' Clinic. The Miriam Hospital, 2016-|
|Associate Hematology Oncology Fellowship Program Director. Warren Alpert Medical School of Brown University, 2015-|
|Attending Hematologist Oncologist. Rhode Island Hospital & The Miriam Hospital, 2014-|
|Assistant Clinical Professor . Warren Alpert Medical School of Brown University, 2014-|
I have served as the Associate Director of the Hematology Oncology Program of Warren Alpert Medical School of Brown University since 2016. I have also been the director of the longitudinal clinic at The Miriam Hospital. In both roles, I serve to teach and mentor fellows in the fundamentals of Hematology Oncology clinical practice. I help teach the core curriculum in breast and gynecololgical malignancy and prepare them for board examination. I have also taught the Brown residents and medical students on the wards, in formal lectures and in my specialty clinics.